OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting c-Met in the treatment of urologic neoplasms: Current status and challenges
Pengxiao Su, Ming Zhang, Xin Kang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Pengxiao Su, Ming Zhang, Xin Kang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Showing 7 citing articles:
New pyrazolopyridine and pyrazolothiazole-based compounds as anti-proliferative agents targeting c-Met kinase inhibition: design, synthesis, biological evaluation, and computational studies
Zahra M. Al-Amshany, Eman M. Algamdi, Ismail M. M. Othman, et al.
RSC Advances (2023) Vol. 13, Iss. 19, pp. 12889-12905
Open Access | Times Cited: 22
Zahra M. Al-Amshany, Eman M. Algamdi, Ismail M. M. Othman, et al.
RSC Advances (2023) Vol. 13, Iss. 19, pp. 12889-12905
Open Access | Times Cited: 22
A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study
Zhaofa Yin, Bohan Liu, Shijian Feng, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 4086-4086
Open Access | Times Cited: 19
Zhaofa Yin, Bohan Liu, Shijian Feng, et al.
Nutrients (2023) Vol. 15, Iss. 18, pp. 4086-4086
Open Access | Times Cited: 19
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment
Antonino Glaviano, Seth A. Wander, Richard D. Baird, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101103-101103
Open Access | Times Cited: 8
Antonino Glaviano, Seth A. Wander, Richard D. Baird, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101103-101103
Open Access | Times Cited: 8
Renal cancer: signaling pathways and advances in targeted therapies
Aimin Jiang, Jinxin Li, Ziwei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Aimin Jiang, Jinxin Li, Ziwei He, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Hepatocyte growth factor promotes retinal pigment epithelium cell activity through MET/AKT signaling pathway
Sirui Zhou, Yu-Sheng Zhu, Wenting Yuan, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 5, pp. 806-814
Closed Access | Times Cited: 1
Sirui Zhou, Yu-Sheng Zhu, Wenting Yuan, et al.
International Journal of Ophthalmology (2024) Vol. 17, Iss. 5, pp. 806-814
Closed Access | Times Cited: 1
Double trouble: how c-MET and HER2 fuel bladder cancer progression
Esraa Mohamed Naguib, EF Ismail, Dahlia I. Badran, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
Esraa Mohamed Naguib, EF Ismail, Dahlia I. Badran, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access
Structural insight into the macrocyclic inhibitor TPX-0022 of c-Met and c-Src
Lingzhi Qu, Hang Lin, Shuyan Dai, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5712-5718
Open Access | Times Cited: 1
Lingzhi Qu, Hang Lin, Shuyan Dai, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5712-5718
Open Access | Times Cited: 1
